During the past decade, Marietta Rheumatology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 13 clinical trials were completed, i.e. on average, 144.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marietta Rheumatology" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "R-Pharm International, LLC" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marietta Rheumatology" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Marietta Rheumatology" are "Rheumatoid Arthritis" (5 trials), "Axial Spondyloarthritis" (2 trials), "Osteoarthritis" (2 trials), "Spondyloarthritis" (2 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "Marietta Rheumatology" in a lesser frequency.

Most popular intervention types in "Marietta Rheumatology" are "Drug" (11 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ixekizumab" (4 trials), "Adalimumab" (2 trials), "Methotrexate" (2 trials) and "Abatacept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marietta Rheumatology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Marietta Rheumatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Marietta Rheumatology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Marietta Rheumatology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".